Published online before print February 26, 2007, doi: 10.1161/HYPERTENSIONAHA.106.085456
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;49:974.)
© 2007 American Heart Association, Inc.
Editorial Commentaries |
Targeting Heme-Oxidized Soluble Guanylate Cyclase
Solution for All Cardiorenal Problems in Heart Failure?
From the Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Mainz, Germany.
Correspondence to Thomas Münzel, II Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. E-mail tmuenzel@uni-mainz.de
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Increased peripheral vascular resistance is a hallmark of advanced chronic congestive heart failure (CHF) and contributes to the phenomenon of increased afterload that complicates that condition. Multiple factors have been proposed to contribute to this phenomenon, such as increased sodium water content of the vasculature, increased activation of neurohormonal vasoconstrictor forces, and intrinsic abnormalities of the vasculature. During the past decade, it has also been shown that CHF is associated with a severe degree of endothelial dysfunction in experimental animals, as well as in humans. Given that the endothelium, as well as endothelium-dependent vasodilation, plays a crucial role in the control of systemic hemodynamics, this phenomenon is probably an important reason for increased vascular resistance and afterload in heart failure. Because the NO–cGMP–cGMP-dependent kinase-1 relaxation pathway is predominantly responsible for the regulation of vascular tone (Figure), numerous studies have examined abnormalities of this pathway in heart failure. Experimental and clinical studies revealed that NO production is decreased because of decreased expression of endothelial NO synthase and diminished endothelial NO synthase–mediated NO production. A further related mechanism related to this is increased production of vascular superoxide anions, which may react with NO in a diffusion-limited reaction to form the highly reactive intermediate peroxynitrite (Figure). Increased superoxide production, however, is clearly not limited to the endothelium, because more recent experimental studies revealed increased oxidative stress throughout the vasculature, including the media and adventitia.1 Oxidative stress within the media reacts with NO formed as it diffuses from the endothelium and also
Related Article:
Hypertension 2007 49: 1128-1133.
This article has been cited by other articles:
 |
|
 |
|
  S. Korkmaz, T. Radovits, E. Barnucz, K. Hirschberg, P. Neugebauer, S. Loganathan, G. Veres, S. Pali, B. Seidel, S. Zollner, et al. Pharmacological Activation of Soluble Guanylate Cyclase Protects the Heart Against Ischemic Injury Circulation, August 25, 2009; 120(8): 677 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lapp, V. Mitrovic, N. Franz, H. Heuer, M. Buerke, J. Wolfertz, W. Mueck, S. Unger, G. Wensing, and R. Frey Cinaciguat (BAY 58-2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure Circulation, June 2, 2009; 119(21): 2781 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Frey, W. Muck, S. Unger, U. Artmeier-Brandt, G. Weimann, and G. Wensing Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58-2667) in Healthy Male Volunteers J. Clin. Pharmacol., December 1, 2008; 48(12): 1400 - 1410. [Abstract] [Full Text] [PDF]
|
|